Suppr超能文献

KDM6B 通过抑制 O6-甲基鸟嘌呤 DNA 甲基转移酶修复和持续的检查点反应促进 PARthanatos。

KDM6B promotes PARthanatos via suppression of O6-methylguanine DNA methyltransferase repair and sustained checkpoint response.

机构信息

Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

出版信息

Nucleic Acids Res. 2022 Jun 24;50(11):6313-6331. doi: 10.1093/nar/gkac471.

Abstract

Poly(ADP-ribose) polymerase-1 (PARP-1) is a DNA damage sensor and contributes to both DNA repair and cell death processes. However, how PARP-1 signaling is regulated to switch its function from DNA repair to cell death remains largely unknown. Here, we found that PARP-1 plays a central role in alkylating agent-induced PARthanatic cancer cell death. Lysine demethylase 6B (KDM6B) was identified as a key regulator of PARthanatos. Loss of KDM6B protein or its demethylase activity conferred cancer cell resistance to PARthanatic cell death in response to alkylating agents. Mechanistically, KDM6B knockout suppressed methylation at the promoter of O6-methylguanine-DNA methyltransferase (MGMT) to enhance MGMT expression and its direct DNA repair function, thereby inhibiting DNA damage-evoked PARP-1 hyperactivation and subsequent cell death. Moreover, KDM6B knockout triggered sustained Chk1 phosphorylation and activated a second XRCC1-dependent repair machinery to fix DNA damage evading from MGMT repair. Inhibition of MGMT or checkpoint response re-sensitized KDM6B deficient cells to PARthanatos induced by alkylating agents. These findings provide new molecular insights into epigenetic regulation of PARP-1 signaling mediating DNA repair or cell death and identify KDM6B as a biomarker for prediction of cancer cell vulnerability to alkylating agent treatment.

摘要

聚(ADP-核糖)聚合酶-1(PARP-1)是一种 DNA 损伤传感器,有助于 DNA 修复和细胞死亡过程。然而,PARP-1 信号如何被调控以切换其从 DNA 修复到细胞死亡的功能在很大程度上仍是未知的。在这里,我们发现 PARP-1 在烷化剂诱导的 PARthanatic 癌细胞死亡中发挥核心作用。赖氨酸去甲基酶 6B(KDM6B)被鉴定为 PARthanatos 的关键调节因子。KDM6B 蛋白缺失或其去甲基酶活性丧失赋予癌细胞对烷化剂诱导的 PARthanatic 细胞死亡的抗性。在机制上,KDM6B 敲除抑制 O6-甲基鸟嘌呤-DNA 甲基转移酶(MGMT)启动子上的甲基化,以增强 MGMT 表达及其直接的 DNA 修复功能,从而抑制 DNA 损伤引发的 PARP-1 过度激活和随后的细胞死亡。此外,KDM6B 敲除触发持续的 Chk1 磷酸化,并激活第二个依赖 XRCC1 的修复机制,以修复逃避 MGMT 修复的 DNA 损伤。MGMT 抑制或检查点反应使缺乏 KDM6B 的细胞对烷化剂诱导的 PARthanatos 重新敏感。这些发现为 PARP-1 信号介导的 DNA 修复或细胞死亡的表观遗传调控提供了新的分子见解,并确定 KDM6B 作为预测癌细胞对烷化剂治疗敏感性的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf35/9226499/00aa4200a52e/gkac471fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验